Cue Biopharma, Inc. (CUE) vs Minerva Neurosciences, Inc. (NERV)
A side-by-side comparison of Cue Biopharma, Inc. and Minerva Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CUE
Cue Biopharma, Inc.
$23.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NERV
Minerva Neurosciences, Inc.
$3.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CUE vs NERV
growth of $100 · dividends reinvested · last 9yCUE -93.0% (-25.6%/yr)NERV -93.3% (-25.9%/yr)CUE compounded faster over this window
CUE NERV
CUE vs NERV: by the numbers
- •CUE is the larger company ($168M vs $160M market cap).
- •Both run net losses; NERV's is the smaller (0.00% vs -435.83% net margin).
Metrics side by side
Valuation
| Metric | CUE | NERV |
|---|---|---|
| P/S ratio | 4.46 | N/A |
| P/B ratio | 72.77 | N/A |
Profitability
| Metric | CUE | NERV |
|---|---|---|
| Gross margin | 99.69% | 0.00% |
| Operating margin | -96.56% | 0.00% |
| Net margin | -435.83% | 0.00% |
| ROE | -7104.24% | N/A |
| ROIC | -1039.56% | -38.56% |
Growth (annualized)
| Metric | CUE | NERV |
|---|---|---|
| Revenue CAGR (5Y) | 47.08% | N/A |
| Total return CAGR (5Y) | -42.42% | -22.14% |
Frequently asked
- How have CUE and NERV total returns compared?
- Over the past 5 years, CUE delivered -42.42% and NERV delivered -22.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cue Biopharma ROEMinerva Neurosciences ROECue Biopharma operating marginMinerva Neurosciences operating marginCue Biopharma revenue growthMinerva Neurosciences revenue growthCue Biopharma free cash flowMinerva Neurosciences free cash flow
Cue Biopharma & Minerva Neurosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.